BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21958874)

  • 1. Antiatherogenic effects of oleanolic acid in apolipoprotein E knockout mice.
    Buus NH; Hansson NC; Rodriguez-Rodriguez R; Stankevicius E; Andersen MR; Simonsen U
    Eur J Pharmacol; 2011 Nov; 670(2-3):519-26. PubMed ID: 21958874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice.
    Gervais M; Pons S; Nicoletti A; Cosson C; Giudicelli JF; Richer C
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):183-9. PubMed ID: 12588757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
    Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
    Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice.
    Guo Y; Zhang C; Du X; Nair U; Yoo TJ
    Hear Res; 2005 Oct; 208(1-2):54-67. PubMed ID: 16051453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
    Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
    Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the nitric oxide system in the anti-atherosclerotic potential of lacidipine in the ApoE-deficient mouse: a morphological, functional, and electrochemical study.
    Cristofori PG; Crivellente FA; Faustinelli I; Lanzoni AR; Lazzarini C; Vecchiato E; Andreoli M; Turton JA; Zancanaro C; Crespi FM
    Toxicol Pathol; 2004; 32(4):493-9. PubMed ID: 15223775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice.
    Xiao HB; Yang ZC; Jia SJ; Li NS; Jiang DJ; Zhang XH; Guo R; Zhou Z; Deng HW; Li YJ
    Life Sci; 2007 Jun; 81(1):1-7. PubMed ID: 17532008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro ATR-FTIR spectroscopic imaging of atherosclerosis: an investigation of the contribution of inducible nitric oxide synthase to lesion composition in ApoE-null mice.
    Palombo F; Shen H; Benguigui LE; Kazarian SG; Upmacis RK
    Analyst; 2009 Jun; 134(6):1107-18. PubMed ID: 19475136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase inhibition by piceatannol-3'-O-β-D-glucopyranoside improves endothelial dysfunction via activation of endothelial nitric oxide synthase in ApoE-null mice fed a high-cholesterol diet.
    Woo A; Shin W; Cuong TD; Min B; Lee JH; Jeon BH; Ryoo S
    Int J Mol Med; 2013 Apr; 31(4):803-10. PubMed ID: 23443634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
    Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions.
    Fransen P; Van Assche T; Guns PJ; Van Hove CE; De Keulenaer GW; Herman AG; Bult H
    Pflugers Arch; 2008 Feb; 455(5):811-8. PubMed ID: 17899169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
    Hu MY; Li YL; Jiang CH; Liu ZQ; Qu SL; Huang YM
    Nutrition; 2008 Oct; 24(10):1030-8. PubMed ID: 18585898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
    Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
    J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
    Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-mediated vasoconstriction in early atherosclerosis is markedly increased in ApoE-/- mouse but prevented by atorvastatin.
    Maguire JJ; Wiley KE; Kuc RE; Stoneman VE; Bennett MR; Davenport AP
    Exp Biol Med (Maywood); 2006 Jun; 231(6):806-12. PubMed ID: 16741003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC; Simari RD; Conover CA
    Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.